<?xml version="1.0" encoding="UTF-8"?>
<p id="p0165">Given ongoing issues with drug shortages in the United States and elsewhere for commonly used agents, planning must also account for the need to identify alternative agents in the event of significant limitations in supply.
 <xref rid="bib29" ref-type="bibr">
  <sup>29</sup>
 </xref> It is worth noting that not all alternative agents are equivalent in efficacy to preferred first-line therapies, as illustrated in recent US shortages of norepinephrine,
 <xref rid="bib30" ref-type="bibr">
  <sup>30</sup>
 </xref> although this may be considered acceptable in a pandemic setting.
</p>
